After 50 years of recognition and study, it is evident that hypertrophic cardiomyopathy (HCM)
is a particularly heterogeneous and unpredictable disease with respect to its clinical …

Pacemaker treatment for bradyarrhythmia was first approved for national health insurance
coverage in Japan in 1974, and its use rapidly became widespread thereafter …

4. Delivery of care and ensuring access to care.............. e108 4.1. Recommendations for the
coordination and delivery of care for adults with CHD and arrhythmias …

In children with structurally normal hearts, the mechanisms of arrhythmias are usually the
same as in the adult patient. Some arrhythmias are particularly associated with young age …

Despite overall favorable acceptance of implantable cardioverter-defibrillators (ICDs),
patients may experience discharges as frightening and painful. The authors reviewed ICD …

Although the primary responsibility for discussion of sexuality and reproductive issues
should fall to the primary care physician, the cardiologist may have more frequent visits with …

Objectives: We characterized a large cohort of children who had a Fontan procedure, with
measures of functional health status, ventricular size and function, exercise capacity, heart …

Objectives: We sought to determine the implications of implantable cardioverter-defibrillator
(ICD) placement in children and patients with congenital heart disease (CHD). Background …

Objective: Recent literature has documented the psychosocial consequences of pediatric
obesity, including poor health‐related quality of life (HRQOL). The present study examines …

Significant mortality benefits have been documented in recipients of implantable
cardioverter defibrillators (ICDs); however, the psychosocial distress created by the …